The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors
Abstract
✓ To characterize some of the genetic events underlying the development of glioblastoma multiforme, the authors analyzed 65 astrocytic tumors (seven pilocytic astrocytomas, eight astrocytomas, 16 anaplastic astrocytomas, and 34 glioblastomas multiforme) for loss of heterozygosity for chromosome 17p, loss of heterozygosity for chromosomes 10p and 10q, amplification of the epidermal growth factor receptor (EGFR) gene, and amplification of the oncogenes N-myc, c-myc, and N-ras using Southern blot analysis. Alterations of the p53 gene (positive immunostaining for p53 protein in tumors with or without p53 gene mutations) in these 65 tumors were analyzed previously. None of the 65 tumors showed amplification or rearrangement of N-myc, c-myc, or N-ras oncogenes. The molecular analysis presented here demonstrates distinct variants of astrocytic tumors, with at least three genetic pathways leading to glioblastoma multiforme. One pathway was characterized by 43 astrocytomas with alterations in p53. Glioblastomas with p53 alterations may represent tumors that progress from lower-grade astrocytomas. This variant was more likely to show loss of chromosome 17p than tumors without p53 alterations (p < 0.04). Seventy-five percent of tumors with loss of one 17p allele demonstrated mutations in the p53 gene. Loss of chromosome 10 was associated with progression from anaplastic astrocytoma (13%) to glioblastoma (38%) (p < 0.04). Amplification of the EGFR gene was a rare (7%) but late event in tumor progression (p < 0.03). A second pathway was characterized by six astrocytomas without p53 alterations and may represent clinically de novo high-grade tumors. These tumors were more likely to show amplification of the EGFR gene (83%) than tumors with p53 alterations. Sixty percent of tumors with EGFR amplification also showed loss of chromosome 10; loss of chromosome 17p was infrequent in this variant. One or more alternative pathways were characterized by 16 astrocytomas without p53 alterations and with none of the genetic changes analyzed in this study. Glioblastomas are a heterogeneous group of tumors that may arise via multiple genetic pathways.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
p53 Mutations in Human Cancers
Hollstein, M., Sidransky, D., Vogelstein, B., & Harris, C. C. (1991) · Science · doi:10.1126/science.1905840 · Cited by 8,018
Lane, D. P. (1992) · Nature · doi:10.1038/358015a0 · Cited by 5,138
The p53 tumour suppressor gene
Levine, A. J., Momand, J., & Finlay, C. A. (1991) · Nature · doi:10.1038/351453a0 · Cited by 3,788
Mutations in the p53 gene occur in diverse human tumour types
Nigro, J. M., Baker, S. J., Preisinger, A. C., Jessup, J. M., Hosteller, R., Cleary, K., Signer, S. H., Davidson, N., Baylin, S., Devilee, P., et al. (1989) · Nature · doi:10.1038/342705a0 · Cited by 2,733
Amplification of a gene encoding a p53-associated protein in human sarcomas
Oliner, J. D., Kinzler, K. W., Meltzer, P. S., George, D. L., & Vogelstein, B. (1992) · Nature · doi:10.1038/358080a0 · Cited by 1,949
Vogelstein, B. (1992) · Cell · doi:10.1016/0092-8674(92)90421-8 · Cited by 1,862
Wong, A. J., Bigner, S. H., Bigner, D. D., Kinzler, K. W., Hamilton, S. R., & Vogelstein, B. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.19.6899 · Cited by 849
Ekstrand, A. J., James, C. D., Cavenee, W. K., Seliger, B., Pettersson, R. F., & Collins, V. P. (1991) · PubMed · Cited by 719
Identification of an Amplified, Highly Expressed Gene in a Human Glioma
Kinzler, K. W., Bigner, S. H., Bigner, D. D., Trent, J. M., Law, M. L., O'Brien, S. J., Wong, A. J., & Vogelstein, B. (1987) · Science · doi:10.1126/science.3563490 · Cited by 681
Clonal expansion of p53 mutant cells is associated with brain tumour progression
Sidransky, D., Mikkelsen, T., Schwechheimer, K., Rosenblum, M. L., Cavanee, W., & Vogelstein, B. (1992) · Nature · doi:10.1038/355846a0 · Cited by 670
Reifenberger, G., Liu, L., Ichimura, K., Schmidt, E., & Collins, V. P. (1993) · PubMed · Cited by 560
Clonal genomic alterations in glioma malignancy stages.
Cd, J., Carlbom, E., Dumanski, J. P., Hansen, M., Nordenskjöld, M., Collins, V. P., & Cavenee, W. K. (1988) · PubMed · Cited by 512
Specific chromosomal abnormalities in malignant human gliomas.
Sh, B., Mark, J., Burger, P. C., Ms, M., Bullard, D. E., Lh, M., & Bigner, D. D. (1988) · PubMed · Cited by 340
Subsets of Glioblastoma Multiforme Defined by Molecular Genetic Analysis
von Deimling, A., von Ammon, K., Schoenfeld, D., Wiestler, O. D., Seizinger, B. R., & Louis, D. N. (1993) · Brain Pathology · doi:10.1111/j.1750-3639.1993.tb00721.x · Cited by 331
Fults, D., Brockmeyer, D. L., Tullous, M. W., Pedone, C. A., & Cawthon, R. (1992) · PubMed · Cited by 292
p53 mutations are associated with 17p allelic loss in grade II and grade III astrocytoma.
von Deimling, A., Eibl, R. H., Ohgaki, H., Louis, D. N., von Ammon, K., Petersen, I., Kleihues, P., Chung, R. Y., Wiestler, O., & Seizinger, B. R. (1992) · PubMed · Cited by 291
Frankel, R. H., Bayona, W., Koslow, M., & Newcomb, E. W. (1992) · PubMed · Cited by 238
Self-citationComparative Study of p53 Gene and Protein Alterations in Human Astrocytic Tumors
Louis, D. N., Deimling, A. V., Chung, R. Y., Rubio, M.-P., Whaley, J. M., Eibl, R. H., Ohgaki, H., Wiestler, O. D., Thor, A. D., & Seizinger, B. R. (1993) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199301000-00005 · Cited by 228
von Deimling, A., Louis, D. N., von Ammon, K., Petersen, I., Hoell, T., Chung, R. Y., Martuza, R. L., Schoenfeld, D. A., Yaşargil, M. G., Wiestler, O. D., et al. (1992) · Journal of Neurosurgery · doi:10.3171/jns.1992.77.2.0295 · Cited by 218
Yamazaki, H., Fukui, Y., Ueyama, Y., Tamaoki, N., Kawamoto, T., Taniguchi, S., & Shibuya, M. (1988) · Molecular and Cellular Biology · doi:10.1128/mcb.8.4.1816 · Cited by 212
von Deimling, A., Louis, D. N., von Ammon, K., Petersen, I., Wiestler, O., & Seizinger, B. R. (1992) · PubMed · Cited by 210
Gene Amplification in Malignant Human Gliomas: Clinical and Histopathologic Aspects
Bigner, S. H., Burger, P. C., Wong, A. J., Werner, M. H., Hamilton, S. R., Muhlbaier, L. H., Vogelstein, B., & Bigner, D. D. (1988) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-198805000-00001 · Cited by 210
Amplification of Epidermal Growth Factor Receptor Gene in Gliomas: Histopathology and Prognosis
Hurt, M. R., Moossy, J., Donovan-Peluso, M., & Locker, J. (1992) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199201000-00010 · Cited by 197
Infrequent p53 gene mutations in medulloblastomas.
Saylors, R. L., Sidransky, D., Friedman, H. S., Bigner, S. H., Bigner, D. D., Vogelstein, B., & Brodeur, G. M. (1991) · PubMed · Cited by 186
Molecular analysis of deletions of the short arm of chromosome 9 in human gliomas.
Olopade, O. I., Jenkins, R. B., Ransom, D. T., Malik, K., Pomykala, H. M., Nobori, T., Cowan, J. M., Rowley, J. D., & Dı́az, M. O. (1992) · PubMed · Cited by 184
Evidence for rearrangement, amplification, and expression of c-myc in a human glioblastoma.
Trent, J., Meltzer, P., Rosenblum, M., Harsh, G., Kinzler, K., Mashal, R., Feinberg, A., & Vogelstein, B. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.2.470 · Cited by 172
Allelotype of human malignant astrocytoma.
Fults, D., Pedone, C. A., Thomas, G. A., & White, R. L. (1990) · PubMed · Cited by 160
TP53 Gene Mutations and 17p Deletions in Human Astrocytomas
Chung, R. Y., Whaley, J. M., Kley, N., Anderson, K., Louis, D. N., Menon, A. G., Hettlich, C., Freiman, R. N., Hedley‐Whyte, E. T., Martuza, R. L., et al. (1991) · Genes Chromosomes and Cancer · doi:10.1002/gcc.2870030502 · Cited by 132
Oncogene amplification in pediatric brain tumors.
Wasson, J., Saylors, R. L., Zeltzer, P. M., Friedman, H. S., Bigner, S. H., Burger, P. C., Bigner, D. D., Look, A. T., Douglass, E. C., & Brodeur, G. M. (1990) · PubMed · Cited by 129
Accumulation of wild type p53 protein in human astrocytomas.
Rubio, M., von Deimling, A., Yandell, D. W., Wiestler, O. D., Gusella, J. F., & Louis, D. N. (1993) · PubMed · Cited by 125
Lang, F. F., Miller, D. C., Pisharody, S., Koslow, M., & Newcomb, E. W. (1994) · PubMed · Cited by 124
Self-citationA Correlative Study of p53 Protein Alteration and p53 Gene Mutation in Glioblastoma Multiforme
Newcomb, E. W., Madonia, W. J., Pisharody, S., Lang, F. F., Koslow, M., & Miller, D. C. (1993) · Brain Pathology · doi:10.1111/j.1750-3639.1993.tb00749.x · Cited by 118
Self-citationLoss of heterozygosity for loci on chromosome 17p in human malignant astrocytoma.
Fults, D., Tippets, R. H., Thomas, G. A., Nakamura, Y., & White, R. L. (1989) · PubMed · Cited by 116
Ransom, D. T., Ritland, S. R., Moertel, C. A., Dahl, R. J., O'Fallon, J. R., Scheithauer, B. W., Kimmel, D. W., Kelly, P. J., Olopade, O. I., Dı́az, M. O., et al. (1992) · Genes Chromosomes and Cancer · doi:10.1002/gcc.2870050412 · Cited by 116
Loss of heterozygosity on chromosome 10 in human glioblastoma multiforme
Fujimoto, M., Fults, D. W., Thomas, G. A., Nakamura, Y., Heilbrun, M. P., White, R. L., Story, J. L., Naylor, S. L., Kagan‐Hallet, K. S., & Sheridan, P. J. (1989) · Genomics · doi:10.1016/0888-7543(89)90302-9 · Cited by 107
Saxena, A., Clark, W. C., Robertson, J. T., Ikejiri, B. L., Oldfield, E. H., & Ali, I. U. (1992) · PubMed · Cited by 94
Molecular mechanisms of oncogenesis.
Seemayer, T. A., & Cavenee, W. K. (1989) · PubMed · Cited by 93
Amplified genes in human gliomas.
Collins, V. P. (1993) · PubMed · Cited by 70
Multiple sequential molecular abnormalities in the evolution of human gliomas
Venter, D. J., & Thomas, D. G. T. (1991) · British Journal of Cancer · doi:10.1038/bjc.1991.168 · Cited by 57
Proto-oncogene analyses in brain tumors
Fujimoto, M., Sheridan, P. J., Sharp, Z. D., Weaker, F. J., Kagan‐Hallet, K. S., & Story, J. L. (1989) · Journal of neurosurgery · doi:10.3171/jns.1989.70.6.0910 · Cited by 50
Loss of constitutional heterozygosity in chromosome 10 in human glioblastoma
Watanabe, K., Nagai, M., Wakai, S., Arai, T., & Kawashima, K. (1990) · Acta Neuropathologica · doi:10.1007/bf00294641 · Cited by 40
Novel combination of c-myc, N-myc and N-ras oncogene alteration in brain tumors
Sauceda, R., Ocadiz‐Delgado, R., Gutiérrez, A. L. F., Salcedo, M., Ortega, V., Figueroa, H. H., & Gariglio, P. (1988) · Molecular Brain Research · doi:10.1016/0169-328x(88)90057-5 · Cited by 8
Cited by
The WHO classification of tumors of the nervous system
Kleihues, P., Louis, D. N., Scheithauer, B. W., Rorke, L. B., Reifenberger, G., Burger, P. C., & Cavenee, W. K. (2002) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/61.3.215 · Cited by 1,547
Malignant glioma: genetics and biology of a grave matter
Maher, E. A., Furnari, F. B., Bachoo, R. M., Rowitch, D. H., Louis, D. N., Cavenee, W. K., & DePinho, R. A. (2001) · Genes & Development · doi:10.1101/gad.891601 · Cited by 1,229
Epidemiology and molecular pathology of glioma
Schwartzbaum, J. A., Fisher, J. L., Aldape, K. D., & Wrensch, M. (2006) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0289 · Cited by 949
Watanabe, K., Tachibana, O., Sato, K., Yonekawa, Y., Kleihues, P., & Ohgaki, H. (1996) · Brain Pathology · doi:10.1111/j.1750-3639.1996.tb00848.x · Cited by 740
Primary and secondary glioblastomas: From concept to clinical diagnosis
Kleihues, P., & Ohgaki, H. (1999) · Neuro-Oncology · doi:10.1093/neuonc/1.1.44 · Cited by 586
Metadata
- Authors
- Lang, F. F., Miller, D. C., Koslow, M., & Newcomb, E. W.
- Venue
- Journal of Neurosurgery
- Published
- 1994-09
- Volume
- 81
- Issue
- 3
- Pages
- 427-436
- ISSN
- 0022-3085 (ISSN-L)
- OpenAlex
- W2063445389
- Cited by
- 300
- References
- 42
- FWCI
- 13.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.